DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $33.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective lowered by Robert W. Baird from $35.00 to $33.00 in a research report released on Friday morning, Benzinga reports. Robert W. Baird currently has a neutral rating on the medical instruments supplier’s stock.

Other equities research analysts have also recently issued research reports about the stock. Needham & Company LLC reaffirmed a buy rating and set a $42.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a neutral rating in a research report on Friday, January 12th. Leerink Partnrs reiterated an outperform rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. SVB Leerink started coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an outperform rating and a $42.00 target price on the stock. Finally, Barrington Research restated an outperform rating and issued a $41.00 price target on shares of DENTSPLY SIRONA in a research report on Thursday, April 18th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and a consensus price target of $36.90.

DENTSPLY SIRONA Stock Down 0.3 %

XRAY opened at $28.29 on Friday. The company has a market cap of $5.87 billion, a PE ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. DENTSPLY SIRONA has a twelve month low of $26.27 and a twelve month high of $41.65. The company has a 50-day moving average price of $32.13 and a 200 day moving average price of $32.71. The company has a quick ratio of 0.95, a current ratio of 1.43 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting analysts’ consensus estimates of $0.42. The business had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.39 earnings per share. Sell-side analysts expect that DENTSPLY SIRONA will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 2.26%. The ex-dividend date was Wednesday, March 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio is -145.45%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of XRAY. GSA Capital Partners LLP purchased a new stake in DENTSPLY SIRONA in the first quarter valued at approximately $655,000. Central Pacific Bank Trust Division acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at $64,000. Financial Counselors Inc. raised its holdings in shares of DENTSPLY SIRONA by 4.2% in the 1st quarter. Financial Counselors Inc. now owns 218,576 shares of the medical instruments supplier’s stock valued at $7,255,000 after buying an additional 8,793 shares during the period. FORA Capital LLC acquired a new position in DENTSPLY SIRONA during the 1st quarter worth about $771,000. Finally, Daiwa Securities Group Inc. boosted its holdings in DENTSPLY SIRONA by 7.9% during the 1st quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock valued at $585,000 after acquiring an additional 1,296 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.